Works matching Chronic myeloid leukemia (CML)


Results: 4567
    1

    Real‐World Efficacy Profile of Compassionate Use of Asciminib in an Italian, Multi‐Resistant Chronic‐Phase Chronic Myeloid Leukemia (CML‐CP) Patient Population.

    Published in:
    Hematological Oncology, 2025, v. 43, n. 3, p. 1, doi. 10.1002/hon.70101
    By:
    • Breccia, Massimo;
    • Rossi, Antonella Russo;
    • Giai, Valentina;
    • Martino, Bruno;
    • Fava, Carmen;
    • Annunziata, Mario;
    • Abruzzese, Elisabetta;
    • Binotto, Gianni;
    • Baratè, Claudia;
    • Nardozza, Aurelio Pio;
    • Misto, Alessandra;
    • Coco, Paola;
    • Calafiore, Valeria;
    • Carraro, Maria Cristina;
    • Cattina, Federica;
    • Cavazzini, Francesco;
    • Corsetti, Maria Teresa;
    • Crucitti, Lara;
    • Crugnola, Monica;
    • Di Veroli, Ambra
    Publication type:
    Article
    2
    3
    4

    Loss of G0/G1 switch gene 2 (G0S2) promotes disease progression and drug resistance in chronic myeloid leukaemia (CML) by disrupting glycerophospholipid metabolism.

    Published in:
    Clinical & Translational Medicine, 2022, v. 12, n. 12, p. 1, doi. 10.1002/ctm2.1146
    By:
    • Gonzalez, Mayra A.;
    • Olivas, Idaly M.;
    • Bencomo‐Alvarez, Alfonso E.;
    • Rubio, Andres J.;
    • Barreto‐Vargas, Christian;
    • Lopez, Jose L.;
    • Dang, Sara K.;
    • Solecki, Jonathan P.;
    • McCall, Emily;
    • Astudillo, Gonzalo;
    • Velazquez, Vanessa V.;
    • Schenkel, Katherine;
    • Reffell, Kelaiah;
    • Perkins, Mariah;
    • Nguyen, Nhu;
    • Apaflo, Jehu N.;
    • Alvidrez, Efren;
    • Young, James E.;
    • Lara, Joshua J.;
    • Yan, Dongqing
    Publication type:
    Article
    5
    6
    7
    8
    9
    10
    11

    Real World Evidence From 2 Decades of First-Line TKI Therapy in Chronic Myeloid Leukemia (CML): Insights From ACHO's RENEHOC Registry.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2025, v. 25, n. 5, p. e290, doi. 10.1016/j.clml.2024.12.015
    By:
    • Polo, Virginia Abello;
    • Sossa, Claudia;
    • Boquimpani, Carla;
    • Antonio Salazar, Luis;
    • Munevar, Isabel;
    • Gómez, Rigoberto;
    • Marcela Cuervo, Diana;
    • Varón Jaimes, Carlos;
    • Reyes, Jheremy;
    • Idrobo, Henry;
    • Omaña, Paola;
    • Daza, Jorge;
    • Pedraza Morales, Julian Eduardo;
    • Agudelo López, Claudia;
    • Quintero-Vega, Guillermo E.;
    • Correa Correa, Mario;
    • Manuel Herrera, Juan;
    • Armando Mantilla, William;
    • Carlos Serrano, Juan;
    • Rosales, Carmen
    Publication type:
    Article
    12
    13
    14

    Randomized comparison of interferon a and hydroxyurea with hydroxyurea monotherapy in chronic myeloid leukemia (CML-study II): prolongation of survival by the combination of interferon a and hydroxyurea.

    Published in:
    Leukemia (08876924), 2003, v. 17, n. 8, p. 1529, doi. 10.1038/sj.leu.2403006
    By:
    • Hehlmann, R;
    • Berger, U;
    • Pfirrmann, M;
    • Hochhaus, A;
    • Metzgeroth, G;
    • Maywald, O;
    • Hasford, J;
    • Reiter, A;
    • Hossfeld, D K;
    • Kolb, H-J;
    • Löffler, H;
    • Pralle, H;
    • Queißer, W;
    • Griesshammer, M;
    • Nerl, C;
    • Kuse, R;
    • Tobler, A;
    • Eimermacher, H;
    • Tichelli, A;
    • Aul, C
    Publication type:
    Article
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29

    Occurrence of L1M Elements in Chromosomal Rearrangements Associated to Chronic Myeloid Leukemia (CML): Insights from Patient-Specific Breakpoints Characterization.

    Published in:
    Genes, 2023, v. 14, n. 7, p. 1351, doi. 10.3390/genes14071351
    By:
    • L'Abbate, Alberto;
    • Moretti, Vittoria;
    • Pungolino, Ester;
    • Micheloni, Giovanni;
    • Valli, Roberto;
    • Frattini, Annalisa;
    • Barcella, Matteo;
    • Acquati, Francesco;
    • Reinbold, Rolland A;
    • Costantino, Lucy;
    • Ferrara, Fulvio;
    • Trojani, Alessandra;
    • Ventura, Mario;
    • Porta, Giovanni;
    • Cairoli, Roberto
    Publication type:
    Article
    30
    31
    32

    Turkish Chronic Myeloid Leukemia Study: Retrospective Sectional Analysis of CML Patients.

    Published in:
    Turkish Journal of Hematology, 2013, v. 30, n. 4, p. 351, doi. 10.4274/tjh.2013.0151
    By:
    • Şahin, Fahri;
    • Saydam, Güray;
    • Cömert, Melda;
    • Uz, Burak;
    • Yavuz, Akif Selim;
    • Turan, Esra;
    • Yönal, İpek;
    • Atay, Hilmi;
    • Kekikli, Engin;
    • Turgut, Mehmet;
    • Pehlivan, Mustafa;
    • Akay, Meltem Olga;
    • Gürkan, Emel;
    • Paydaş, Semra;
    • Kahraman, Selda;
    • Demirkan, Fatih;
    • Klrklzlar, Onur;
    • Akpınar, Seval;
    • Pamuk, Gülsüm Emel;
    • Demir, Muzaffer
    Publication type:
    Article
    33
    34
    35
    36

    A multicenter retrospective evaluation of Chronic Myeloid Leukemia (CML) therapy in Austria assessing the impact of early treatment response on patient outcomes in a real-life setting: R-EFECT study.

    Published in:
    Wiener Klinische Wochenschrift, 2020, v. 132, n. 15/16, p. 415, doi. 10.1007/s00508-020-01690-1
    By:
    • Petzer, Andreas L.;
    • Sperr, Wolfgang R.;
    • Buxhofer-Ausch, Veronika;
    • Sliwa, Thamer;
    • Schmidt, Stefan;
    • Greil, Richard;
    • Wölfler, Albert;
    • Pichler, Petra;
    • Dormann, Clemens;
    • Burgstaller, Sonja;
    • Tinchon, Christoph;
    • Lang, Alois;
    • Goebel, Florian;
    • Uthman, Shanow;
    • Muenchmeier, Niklas;
    • Valent, Peter
    Publication type:
    Article
    37
    38
    39
    40

    Deciphering Potential Molecular Signatures to Differentiate Acute Myeloid Leukemia (AML) with BCR::ABL1 from Chronic Myeloid Leukemia (CML) in Blast Crisis.

    Published in:
    International Journal of Molecular Sciences, 2023, v. 24, n. 20, p. 15441, doi. 10.3390/ijms242015441
    By:
    • Boucher, Lara;
    • Sorel, Nathalie;
    • Desterke, Christophe;
    • Chollet, Mélanie;
    • Rozalska, Laura;
    • Gallego Hernanz, Maria Pilar;
    • Cayssials, Emilie;
    • Raimbault, Anna;
    • Bennaceur-Griscelli, Annelise;
    • Turhan, Ali G.;
    • Chomel, Jean-Claude
    Publication type:
    Article
    41
    42
    43
    44
    45
    46
    47

    Bone Marrow CD34+/lin− Cells of Patients with Chronic-Phase Chronic Myeloid Leukemia (CP-CML) After 12 Months of Nilotinib Treatment Exhibit a Different Gene Expression Signature Compared to the Diagnosis and the Corresponding Cells from Healthy Subjects

    Published in:
    Cancers, 2025, v. 17, n. 6, p. 1022, doi. 10.3390/cancers17061022
    By:
    • Trojani, Alessandra;
    • Pungolino, Ester;
    • Di Camillo, Barbara;
    • Bossi, Luca Emanuele;
    • Palumbo, Cassandra;
    • D'adda, Mariella;
    • Perego, Alessandra;
    • Turrini, Mauro;
    • Elena, Chiara;
    • Borin, Lorenza Maria;
    • Iurlo, Alessandra;
    • Malato, Simona;
    • Spina, Francesco;
    • Latargia, Maria Luisa;
    • Spedini, Pierangelo;
    • Artale, Salvatore;
    • Anghilieri, Michela;
    • Carraro, Maria Cristina;
    • Bucelli, Cristina;
    • Beghini, Alessandro
    Publication type:
    Article
    48

    Minimal Residual Disease Detection at RNA and Leukemic Stem Cell (LSC) Levels: Comparison of RT-qPCR, d-PCR and CD26+ Stem Cell Measurements in Chronic Myeloid Leukemia (CML) Patients in Deep Molecular Response (DMR).

    Published in:
    Cancers, 2023, v. 15, n. 16, p. 4112, doi. 10.3390/cancers15164112
    By:
    • Abruzzese, Elisabetta;
    • Bocchia, Monica;
    • Trawinska, Malgorzata Monika;
    • Raspadori, Donatella;
    • Bondanini, Francesco;
    • Sicuranza, Anna;
    • Pacelli, Paola;
    • Re, Federica;
    • Cavalleri, Alessia;
    • Farina, Mirko;
    • Malagola, Michele;
    • Russo, Domenico;
    • De Fabritiis, Paolo;
    • Bernardi, Simona
    Publication type:
    Article
    49
    50